News
NewsBY
- A longtime MP who saw the rise, fall, and resurrection of the Liberal Party, Chrystia Freeland was praised for a record of notable accomplishments as she departs Ottawa after more than a decade in politics.
NewsBY
- A longtime MP who saw the rise, fall, and resurrection of the Liberal Party, Chrystia Freeland was praised for a record of notable accomplishments as she departs Ottawa after more than a decade in politics.
NewsBY
- In 2026, 98.8 per cent of Canadian homes are expected to have access to high-speed broadband, surpassing the Liberal government’s goal of 95 per cent set in 2019. But only 16.7 per cent of Nunavut homes are projected to meet that mark next year.
NewsBY
- In 2026, 98.8 per cent of Canadian homes are expected to have access to high-speed broadband, surpassing the Liberal government’s goal of 95 per cent set in 2019. But only 16.7 per cent of Nunavut homes are projected to meet that mark next year.
NewsBY
- When asked by the CBC about the floor-crossing Conservatives, Leader Pierre Poilievre framed the issue as 'a problem of [Mark] Carney’s leadership,' accusing the prime minister of 'trying to manipulate his way through backroom deals to get that majority.'
NewsBY
- When asked by the CBC about the floor-crossing Conservatives, Leader Pierre Poilievre framed the issue as 'a problem of [Mark] Carney’s leadership,' accusing the prime minister of 'trying to manipulate his way through backroom deals to get that majority.'
NewsBY
- While key reforms to cement the new multi-group Senate have been passed, ‘there’s no guarantee that independence is forever,’ warns outgoing ISG Facilitator Raymonde Saint-Germain.
NewsBY
- While key reforms to cement the new multi-group Senate have been passed, ‘there’s no guarantee that independence is forever,’ warns outgoing ISG Facilitator Raymonde Saint-Germain.
NewsBY
- But that doesn’t mean the drug pricing tribunal can’t look at past years’ data to inform future reviews of drug prices, says director general Guillaume Couillard.
NewsBY
- But that doesn’t mean the drug pricing tribunal can’t look at past years’ data to inform future reviews of drug prices, says director general Guillaume Couillard.
COVID-19
